Severity
Low
FDA Drug recall · Reported February 20, 2019
Defective Container; complaints of leakage.
Oxalis Labs recalled Clobetasol Propionate Topical Solution USP, 0.05% w/w, 50 mL bottle, Manufactured for: Ma… - a low-severity action.
Clobetasol Propionate Topical Solution USP, 0.05% w/w, 50 mL bottle, Manufactured for: Ma… was recalled by Oxalis Labs in February 20, 2019. Reason: Defective Container; complaints of leakage.. Check the official notice for the remedy. Verify recall #D-0492-2019 with the FDA Drug before acting.
The recall
Oxalis Labs issued this low-severity FDA Drug recall-Defective Container; complaints of leakage..
Sourced from official FDA Drug enforcement records. Verify recall #D-0492-2019 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0492-2019) was formally reported on February 20, 2019, with the manufacturer initiating the action on January 11, 2019. It is classified under Low severity (Class III), with a current status of Terminated. Oxalis Labs is listed as the recalling firm, operating out of Theda, N/A. Federal records list the affected scope as 53,358 bottles.
The documented reason for this recall is: Defective Container; complaints of leakage. Distribution data in the federal record shows the product reached: Product was distributed to 4 major distributors in IL, NY, AR, KY who may have further distribute the product throughout the United States.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 3,772 children & baby products recalls on record
Of 88,001 recalls with an agency hazard classification, 19,020 are high severity, 64,468 moderate, and 4,513 low. A further 16,157 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
53,358 bottles
Related Recalls
6
0 from same agency
Clobetasol Propionate Topical Solution USP, 0.05% w/w, 50 mL bottle, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufacturer: Macleods Pharmaceuticals Ltd Al Oxalis Labs Baddi Himachal Pradesh INDIA, UPC Code 33342032186 ---- NDC 33342-321-86
Defective Container; complaints of leakage.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-0492-2019 |
| Date reported | February 20, 2019 |
| Date initiated | January 11, 2019 |
| Recalling firm | Oxalis Labs |
| Firm location | Theda, N/A |
| Affected scope | 53,358 bottles |
| Distribution | Product was distributed to 4 major distributors in IL, NY, AR, KY who may have further distribute the product throughout the United States. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Two federal-filing-derived peer sets for this notice, both outside the same recalling firm and filing state so the neighborhoods are not firm or geographic containment.
Same archive severity grade (Low), closest by report date among other firms and states.
Same product category, closest by report date among other firms and states (deduped against the severity set).
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Showing 5 of 4006 other recalls in this category.
EEMB USA, doing business as A2batt, Inc., of Redlands, California · 2026-08-06
Shenzhen Okabesini Technology Co., Ltd., dba Okabesini-us, of China · 2026-08-06
· 2026-08-06
Changsha Yuelu District Ruiwu E-Commerce Co., Ltd., dba WURUI.BABY, of China · 2026-08-06
· 2026-07-30
Compare this recall with A2batt Recalls EEMB Lithium Coin Battery Chargers Due to Ri… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported February 20, 2019. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.